City
Epaper

Study suggests new depression screeners successfully measure symptoms, follow treatment's progress

By ANI | Updated: October 23, 2021 21:35 IST

Research from Regenstrief Institute and Indiana University School of Medicine has shown that the Patient-Reported Outcomes Measurement Information Systems (PROMIS) scale for depression developed by the National Institutes of Health can accurately measure depression symptoms and its severity.

Open in App

Research from Regenstrief Institute and Indiana University School of Medicine has shown that the Patient-Reported Outcomes Measurement Information Systems (PROMIS) scale for depression developed by the National Institutes of Health can accurately measure depression symptoms and its severity.

The findings of the study were published in the 'Journal of Psychosomatic Research'.

"Depression is treatable, that's why routine screening is strongly recommended," said study lead author Dr Kurt Kroenke, M.D., Regenstrief research scientist and IU School of Medicine professor of medicine.

"Measurement-based care is important to track a patient's progress in order to make adjustments to care when needed. This study found that the PROMIS scales are an accurate measure of depression to aid in diagnosis and treatment," added Dr Kroenke.

The research team analyzed data from three randomized clinical trials involving about 650 patients. It compared the results of the PROMIS scale, which is a survey where patients report their symptoms, to the results of a structured psychiatric interview.

They also compared the diagnostic performance of the PROMIS scale and Patient Health Questionnaire nine-item depression scale (PHQ-9), which has been validated and widely adopted around the world, to benchmark the PROMIS measures. The PHQ-9 was developed by Dr Kroenke.

Data analysis showed that PROMIS and PHQ-9 depression scales have similar accuracy when diagnosing depression.

"PROMIS scales are already commonly in use, and both PROMIS and PHQ scales are accessible and free in the public domain. This research supports both as viable screening options," said Dr Kroenke.

"The pandemic has taken a substantial toll on mental health, and there will likely be a lingering effect. Screening has become all the more important because we must be able to diagnose and treat patients who are suffering. Monitoring depression is no different than monitoring blood pressure, so these scales are important tools that are proven to work," added Dr Kroenke.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Regenstrief Institute, Inc.Indiana university school of medicine
Open in App

Related Stories

HealthStudy finds risk factors for early-onset colorectal cancer in males

HealthResearchers reveal how looking at clock while trying to sleep affects insomnia

TechnologyResearchers reveal how watching clock while trying to sleep impacts insomnia

HealthResearchers develop blood test for anxiety

HealthNow a simple blood test may help detect anxiety

Health Realted Stories

HealthCentre extends financial aid to indigenous indoor air purification solution

HealthChildhood exposure to bacterial toxin can trigger Colorectal cancer among the young: Study

HealthIndia achieves breakthrough in gene therapy for haemophilia: Minister

LifestyleWalking Tips for Summer: Know the Best time to Walk to Avoid Heatstroke

HealthCentre launches campaign to achieve 100 pc Measles-Rubella immunisation coverage